Trials / Completed
CompletedNCT05526872
A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening
Patient Reminders and Self-Referrals Via Online Patient Portals and Text Messaging (PReVenT) to Improve Adherence to Breast Cancer Screening
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- Female
- Age
- 50 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial evaluates the patient reminders and self-referrals via online patient portals and text messaging (PReVenT) intervention for improving adherence to breast cancer screening. Though no doctor referral is required for mammography, adherence to screening mammograms remains low. Barriers to screening mammography can include things like forgetfulness, low motivation, high cost, or lack of knowledge. Patient reminders and self-scheduling assistance may overcome some of these barriers by increasing patients' awareness, motivating them to schedule their mammogram, and improving access by removing the need for a healthcare provider to order the exam. The PReVenT intervention uses online and text-message based patient-reminders and self-referral assistance to increase adherence to breast cancer screening.
Detailed description
PRIMARY OBJECTIVES; I. Compare the screening mammogram (SM) completion rates between PReVenT and enhanced usual care (EUC) arms at 6 months. II. Describe patient's experience with the PReVenT intervention using mixed methods stratified by completion of SM. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive usual care as well as a portal message reminder to schedule a SM and a callback link if they need assistance. Participants who have not or do not schedule their SM at the time of the first reminder receive a reminder text-message one week later with a link to receive assistance with scheduling. ARM II: Participants receive usual care as well as portal and text messages one week apart with educational materials about healthy eating. After completion of study, patients are followed up at 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Best Practice | Receive usual care |
| BEHAVIORAL | Health Education | Receive educational materials |
| OTHER | Interview | Ancillary studies |
| OTHER | Planned Notification | Receive planned reminders to schedule mammogram |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2022-09-05
- Primary completion
- 2024-03-31
- Completion
- 2024-06-01
- First posted
- 2022-09-02
- Last updated
- 2024-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05526872. Inclusion in this directory is not an endorsement.